Abstract
IntroductionTwo groups of biological therapies are licensed and approved by NICE for the management of moderate to severe UC in the UK. The anti-TNF drugs, Infliximab (IFX), Adalimumab (ADA) and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have